Seth and Nick discuss how technology is used to develop regenerative medicine for conditions such as Parkinson’s disease and Alzheimer’s disease. Seth Ettenberg is CEO and President of BlueRock Therapeutics, a wholly owned subsidiary of Bayer. He’s a biotech entrepreneur, on the cutting edge of something called regenerative medicine. …
The post Biotech expert Seth Ettenberg and Nick discuss a potential cure for Parkinson’s disease appeared first on Public Words.
Go to Source
Author: Emma Wyatt
